American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

From the Field

President’s Cancer Panel Hosts Virtual Meetings

The President’s Cancer Panel will host a series of virtual meetings to explore the impact of COVID-19 on cancer screening—Improving Resilience and Equity in Cancer Screening: Lessons from COVID-19 and Beyond. The massive disruption caused by COVID-19 has provided an opportunity to take lessons learned from the ongoing disturbance and create lasting improvements in screening. The panel monitors the activities of the National Cancer Program (NCP) and reports to the President of the United States on barriers to progress in reducing the burden of cancer.

In the coming months, the panel will conduct a series of meetings to discuss the effects of COVID-19 on cancer screening across four cancer types—cervical cancer, breast cancer, colorectal cancer, and lung cancer. The goal is to explore specific issues deemed critical to the NCP and develop strategies to accelerate improvements in the area of cancer screening across these four tumor types and in cancer screening in general. The panel meeting will be webcast and will include an opportunity for stakeholders and the public to provide input and ask questions during the public comment portion of the meeting.

Information on the dates and times of the meeting is below.

Virtual Meeting Dates and Times

Colorectal Cancer Day 1: November 2, 2020, 1:00–5:00 pm EST
Colorectal Cancer Day 2: November 4, 2020, 1:00–5:00 pm EST

Cervical Cancer Day 1: November 9, 2020, 1:00–5:00 pm EST
Cervical Cancer Day 2: November 10, 2020, 1:00–5:00 pm EST

Breast Cancer Day 1: November 16, 2020, 1:00–5:00 pm EST
Breast Cancer Day 2: November 18, 2020, 1:00–5:00 pm EST

Please also feel free to share the details of the webcast with any colleagues or constituents who may be interested. Registration is not necessary, and the webcast is open to the public without charge.

Use this link to view the webcast on the day of the meeting.

For additional information about the Panel, please refer to the official Panel website.